JP2019510807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510807A5 JP2019510807A5 JP2018553149A JP2018553149A JP2019510807A5 JP 2019510807 A5 JP2019510807 A5 JP 2019510807A5 JP 2018553149 A JP2018553149 A JP 2018553149A JP 2018553149 A JP2018553149 A JP 2018553149A JP 2019510807 A5 JP2019510807 A5 JP 2019510807A5
- Authority
- JP
- Japan
- Prior art keywords
- bchl
- mdsc
- inhibitor
- mdsc inhibitor
- rgd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021193514A JP2022031823A (ja) | 2016-04-10 | 2021-11-29 | バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662320549P | 2016-04-10 | 2016-04-10 | |
| US62/320,549 | 2016-04-10 | ||
| PCT/IL2017/050440 WO2017179053A1 (en) | 2016-04-10 | 2017-04-10 | Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021193514A Division JP2022031823A (ja) | 2016-04-10 | 2021-11-29 | バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019510807A JP2019510807A (ja) | 2019-04-18 |
| JP2019510807A5 true JP2019510807A5 (https=) | 2020-05-14 |
Family
ID=58794130
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553149A Pending JP2019510807A (ja) | 2016-04-10 | 2017-04-10 | バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法 |
| JP2021193514A Pending JP2022031823A (ja) | 2016-04-10 | 2021-11-29 | バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021193514A Pending JP2022031823A (ja) | 2016-04-10 | 2021-11-29 | バクテリオクロロフィル誘導体を含む、がんの治療のための併用療法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11278555B2 (https=) |
| EP (1) | EP3442582A1 (https=) |
| JP (2) | JP2019510807A (https=) |
| KR (2) | KR20190008206A (https=) |
| CN (2) | CN118304400A (https=) |
| AU (2) | AU2017250732B2 (https=) |
| BR (1) | BR112018070847A2 (https=) |
| CA (1) | CA3020067A1 (https=) |
| IL (1) | IL262191B2 (https=) |
| MX (2) | MX390751B (https=) |
| RU (2) | RU2021110230A (https=) |
| SG (1) | SG11201808849TA (https=) |
| WO (1) | WO2017179053A1 (https=) |
| ZA (1) | ZA201807187B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10107240B2 (en) | 2014-04-04 | 2018-10-23 | Dayco Ip Holdings, Llc | Check valves and Venturi devices having the same |
| CN106458190B (zh) | 2014-05-30 | 2019-12-06 | 戴科知识产权控股有限责任公司 | 具有喷射器、气动控制阀和可选择的吸气器的真空创建系统 |
| EP3723785A1 (en) * | 2017-12-17 | 2020-10-21 | Yeda Research and Development Co. Ltd | Cop9 signalosome (csn) complex modulators and uses thereof |
| WO2022149934A1 (ko) * | 2021-01-08 | 2022-07-14 | 가톨릭대학교 산학협력단 | 암세포의 항암 면역치료를 위한 항체-폴리에틸렌글리콜-광감각제 접합체 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE347554T1 (de) | 1998-12-09 | 2006-12-15 | Yeda Res & Dev | Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung |
| IL133253A0 (en) * | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| PT2061512T (pt) | 2006-08-23 | 2020-01-14 | Yeda Res & Dev | Conjugados de péptidos com rgd e fotossensibilizantes de (bacterio)clorofila e as suas utilizações |
| US8673270B2 (en) | 2008-10-23 | 2014-03-18 | Steba Biotech S.A. | RGD-containing peptidomimetics and uses thereof |
| WO2012106343A2 (en) * | 2011-02-01 | 2012-08-09 | The Board Of Trustees Of The University Of Illinois | Hdac inhibitors and therapeutic methods using the same |
| TWI442945B (zh) * | 2011-05-18 | 2014-07-01 | Univ Nat Taiwan | 雙效微脂體用於治療的方法 |
| WO2014141289A1 (en) * | 2013-03-12 | 2014-09-18 | Amrita Vishwa Vidyapeetham University | Photo - chemo composition on the basis of microcapsules with a core -shell structure |
-
2017
- 2017-04-10 KR KR1020187032029A patent/KR20190008206A/ko not_active Abandoned
- 2017-04-10 BR BR112018070847A patent/BR112018070847A2/pt not_active Application Discontinuation
- 2017-04-10 CN CN202410235521.9A patent/CN118304400A/zh active Pending
- 2017-04-10 MX MX2018012392A patent/MX390751B/es unknown
- 2017-04-10 US US16/092,742 patent/US11278555B2/en active Active
- 2017-04-10 WO PCT/IL2017/050440 patent/WO2017179053A1/en not_active Ceased
- 2017-04-10 JP JP2018553149A patent/JP2019510807A/ja active Pending
- 2017-04-10 SG SG11201808849TA patent/SG11201808849TA/en unknown
- 2017-04-10 CN CN201780035366.4A patent/CN109862918A/zh active Pending
- 2017-04-10 KR KR1020227034306A patent/KR20220139445A/ko not_active Abandoned
- 2017-04-10 RU RU2021110230A patent/RU2021110230A/ru unknown
- 2017-04-10 RU RU2018139523A patent/RU2747258C2/ru active
- 2017-04-10 CA CA3020067A patent/CA3020067A1/en active Pending
- 2017-04-10 IL IL262191A patent/IL262191B2/en unknown
- 2017-04-10 AU AU2017250732A patent/AU2017250732B2/en active Active
- 2017-04-10 EP EP17726380.3A patent/EP3442582A1/en not_active Withdrawn
-
2018
- 2018-10-10 MX MX2022003190A patent/MX2022003190A/es unknown
- 2018-10-26 ZA ZA2018/07187A patent/ZA201807187B/en unknown
-
2021
- 2021-11-29 JP JP2021193514A patent/JP2022031823A/ja active Pending
-
2022
- 2022-03-21 US US17/700,063 patent/US20220202838A1/en not_active Abandoned
-
2023
- 2023-02-06 AU AU2023200591A patent/AU2023200591A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7562296B2 (ja) | がんの処置のための併用治療 | |
| AU2022202392A1 (en) | Combination therapies of HDAC inhibitors and PD-1 inhibitors | |
| EA201890146A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ СОЛИДНЫХ ОПУХОЛЕЙ С ИСПОЛЬЗОВАНИЕМ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ | |
| NZ703047A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents | |
| PH12020500665A1 (en) | Pladienolide derivatives as spliceosome targeting agents for treating cancer | |
| EA201650134A1 (ru) | Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором | |
| JP2019510807A5 (https=) | ||
| PH12020500666A1 (en) | Pladienolide compounds and their use | |
| JP2018529780A5 (https=) | ||
| JP2020523354A5 (https=) | ||
| Kim et al. | Procarbazine and CCNU chemotherapy for recurrent glioblastoma with MGMT promoter methylation | |
| MX2022008216A (es) | Tratamiento de cancer en combinacion usando un antagonista de pd-1, un antagonista de ilt4 y lenvatinib o sales del mismo. | |
| JP2016515586A5 (https=) | ||
| Kumar et al. | Hypoxia-targeting drug evofosfamide (TH-302) enhances sunitinib activity in neuroblastoma xenograft models | |
| JP2016509050A5 (https=) | ||
| CY1123861T1 (el) | Θεραπευτικη αντιμετωπιση εξαψεων και οστικης απωλειας, επαγομενων απο θεραπεια στερησης ανδρογονων, με χρηση cis-κλομιφαινης | |
| MX2021003681A (es) | Composiciones y metodos para el tratamiento de desordenes inflamatorios. | |
| BR112021006318A2 (pt) | terapia de combinação para o tratamento de câncer | |
| RU2021110230A (ru) | Комбинированные способы терапии для лечения злокачественной опухоли | |
| Qiu et al. | Clinical study of cetuximab combined with radical radiotherapy in the treatment of locally advanced sinonasal squamous cell carcinoma | |
| Marcu | Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin‐Based Treatments | |
| RU2018114457A (ru) | Лечение syd985 пациентов с t-dm1 рефрактерным раком | |
| MX2023010394A (es) | Metodos para tratar el cancer usando una combinacion de regimenes de dosificacion de serd. | |
| Dickie et al. | Adjuvant radiation for soft tissue sarcomas | |
| JP2020502182A5 (https=) |